UNIVERSITY OF CALIFORNIA, IRVINE

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1965-01-01

Employees: 10K

Market Cap: -

Website: http://www.uci.edu

Clinical Trials

Physical Activity in Acute Lymphoblastic Leukemia (ALL)

Not Applicable

Completed

Conditions: Acute Leukemia

First Posted Date: 2025-01-20

Last Posted Date: 2025-01-20

Lead Sponsor: University of California, Irvine

Target Recruit Count: 21

Registration Number: NCT06783738

Metronomic Cyclophosphamide With Pembrolizumab in Checkpoint Inhibitor Refractory Melanoma

Phase 2

Recruiting

Conditions: Melanoma
Melanoma Stage III
Melanoma (Skin)
Melanoma Stage IV

Interventions: Drug: Pembrolizumab
Drug: Cyclophosphamide

First Posted Date: 2025-01-13

Last Posted Date: 2025-01-13

Lead Sponsor: University of California, Irvine

Target Recruit Count: 14

Registration Number: NCT06771544

Locations: 🇺🇸
Chao Family Comprehensive Cancer Center University of California, Irvine, Orange, California, United States

EndoPAT Device for Endothelial Dysfunction in ED

Not Applicable

Not yet recruiting

Conditions: Erectile Dysfunction
Hypogonadism, Male
Endothelial Dysfunction

Interventions: Drug: Daily low-dose PDE5 inhibitor therapy
Drug: Testosterone therapy as per clinical guidelines.

First Posted Date: 2024-12-06

Last Posted Date: 2025-04-11

Lead Sponsor: University of California, Irvine

Target Recruit Count: 120

Registration Number: NCT06720597

Locations: 🇺🇸
UCI Urology | Men's Health Center, Newport Beach, California, United States

Single-Center Eval of Clinical & Radiological Benefit AHCC in Combo W/ SOC Tx for HPV+ Pts W/ HNSCC

Phase 2

Recruiting

Conditions: HNSCC
Head and Neck Squamous Cell Carcinoma

Interventions: Drug: AHCC®capsules

First Posted Date: 2024-11-18

Last Posted Date: 2025-03-27

Lead Sponsor: University of California, Irvine

Target Recruit Count: 34

Registration Number: NCT06693323

Locations: 🇺🇸
Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange, California, United States

Vaginal Changes After CO2 Laser

Not Applicable

Recruiting

Conditions: Genitourinary Syndrome of Menopause

First Posted Date: 2024-11-15

Last Posted Date: 2024-11-15

Lead Sponsor: University of California, Irvine

Target Recruit Count: 50

Registration Number: NCT06691178

Locations: 🇺🇸
Beckman Laser Institute, Irvine, California, United States

Adjuvant Sacituzumab Govitecan and Nivolumab in Muscle-Invasive Urothelial Carcinoma At High-Risk Recurrence

Phase 2

Recruiting

Conditions: Urothelial Carcinoma
Muscle-invasive Bladder Cancer

Interventions: Drug: Sacituzumab Govitecan (SG)
Drug: Nivolumab

First Posted Date: 2024-11-12

Last Posted Date: 2025-03-26

Lead Sponsor: University of California, Irvine

Target Recruit Count: 23

Registration Number: NCT06682728

Locations: 🇺🇸
Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange, California, United States

Intervention Development and Evaluation to Reduce Disparities in Quality of Life for Latino Families Impacted by Cancer

Not Applicable

Active, not recruiting

Conditions: Quality of Life
Pediatric Cancer
Caregiver Burden

Interventions: Other: 13-week session program

First Posted Date: 2024-10-02

Last Posted Date: 2025-02-07

Lead Sponsor: University of California, Irvine

Target Recruit Count: 33

Registration Number: NCT06622252

Locations: 🇺🇸
CHOC Children's, Orange, California, United States

Targeted Nutritional Supplement After Lumbar Spine Surgery: A Randomized, Placebo-Controlled, Double-Blind Trial

Not Applicable

Not yet recruiting

Conditions: Lumbar Spinal Stenosis

Interventions: Dietary Supplement: Alanine
Dietary Supplement: Essential amino acids

First Posted Date: 2024-08-30

Last Posted Date: 2024-11-19

Lead Sponsor: University of California, Irvine

Target Recruit Count: 88

Registration Number: NCT06579391

Locations: 🇺🇸
University of California Irvine Medical Center, Orange, California, United States

The Effects of Core Shamanism in Fibromyalgia

Not Applicable

Recruiting

Conditions: Fibromyalgia

Interventions: Other: Core Shamanism

First Posted Date: 2024-08-30

Last Posted Date: 2024-08-30

Lead Sponsor: University of California, Irvine

Target Recruit Count: 25

Registration Number: NCT06579261

Locations: 🇺🇸
Susan Samueli Integrative Health Institute, Irvine, California, United States

Repurposing Riluzole for Cancer-Related Cognitive Impairment: a Pilot Trial

Phase 2

Recruiting

Conditions: Breast Cancer

Interventions: Drug: Riluzole
Drug: Placebo

First Posted Date: 2024-08-30

Last Posted Date: 2025-03-27

Lead Sponsor: University of California, Irvine

Target Recruit Count: 34

Registration Number: NCT06580002

Locations: 🇺🇸
Chao Family Comprehensive Cancer Center, University of California Irvine, Orange, California, United States

Home Terms & Conditions Privacy Policy